Skip to search formSkip to main contentSkip to account menu

ovarian neoplasm

Known as: Neoplasm of the ovaries, Neoplasms, Ovary, ovarian tumour 
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface… 
National Institutes of Health

Related topics

Related topics

50 relations
0.5 ML choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe1 ML Leuprolide Acetate 11.25 MG/ML Prefilled Syringe [Lupron]1 ML Leuprolide Acetate 7.5 MG/ML Prefilled Syringe [Lupron]1.5 ML Leuprolide Acetate 20 MG/ML Prefilled Syringe [Lupron]

Narrower (7)

Achard-Thiers syndromeEpithelial ovarian cancerLuteomaMalignant Ovarian Germ Cell Neoplasm

Broader (3)

Endocrine Gland NeoplasmsGenital Neoplasms, FemaleOvarian Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Single-quantum-dot-based DNA nanosensor
Rapid and highly sensitive detection of DNA is critical in diagnosing genetic diseases. Conventional approaches often rely on… 
Highly Cited
2004
Highly Cited
2004
A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent.
We synthesized a MCM-41-type mesoporous silica nanosphere (MSN)-based gene transfection system, where second generation (G2… 
Highly Cited
2003
Highly Cited
2003
International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer.
BACKGROUND The question of whether platinum-based adjuvant chemotherapy can improve outcomes in patients with early-stage… 
Review
2003
Review
2003
CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin: An Immunohistochemical Survey of 476 Primary and Metastatic Carcinomas
CDX2 is a recently cloned homeobox gene that encodes an intestine-specific transcription factor, expressed in the nuclei of… 
Highly Cited
2001
Highly Cited
2001
The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*
BRCA1-BARD1 constitutes a heterodimeric RING finger complex associated through its N-terminal regions. Here we demonstrate that… 
Highly Cited
2000
Highly Cited
2000
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.
BACKGROUND A randomized trial conducted by the Gynecologic Oncology Group (GOG, study #111) in the United States showed a better… 
Highly Cited
1999
Highly Cited
1999
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers
Previous studies have demonstrated a synergistic interaction between rhuMAb HER2 and the cytotoxic drug cisplatin in human breast… 
Highly Cited
1994
Highly Cited
1994
Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families
We provide genetic evidence supporting the identity of the candidate gene for BRCA1 through the characterization of germline… 
Highly Cited
1993
Highly Cited
1993
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.
Breast cancer is known to have an inherited component, consistent in some families with autosomal dominant inheritance; in such… 
Highly Cited
1992
Highly Cited
1992
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.
BACKGROUND Mutations of the tumor suppressor gene p53 have been identified in breast cancer cell lines, and some breast… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)